Trial reportBMC health services research2026
Advancing youth HIV prevention and care in Uganda: stakeholder-informed innovations through implementation science, protocol for a randomized controlled trial.
Trial report in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06474364 (Using Implementation Science to Understand and Design Stakeholder Informed Innovative Interventions to Improve Youth HIV Prevention and Care Continuums in Rural and Urban Uganda.), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Using Implementation Science to Understand and Design Stakeholder Informed Innovative Interventions to Improve Youth HIV Prevention and Care Continuums in Rural and Urban Uganda.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCompared with older adults, adolescents and young adults (AYA) face greater HIV incidence and poorer outcomes across the HIV prevention and care continuum. Despite the high HIV burden, youth in sub-Saharan Africa have suboptimal uptake rates of oral preexposure prophylaxis (PrEP) and viral suppression. Although effective interventions are available, AYA exhibit low uptake and persistence due to stigma, pill burden, and accessibility challenges. The HIV Prevention and Care Interventions for Youth in Uganda (HIP-CY) study aims to explore the adoption and effectiveness of cabotegravir (CAB LA), a new long-acting injectable antiretroviral and highly efficacious PrEP choice that can mitigate barriers to the use of daily oral PrEP among AYA at heightened risk of HIV acquisition, and the SEARCH-YOUTH intervention, an efficacious multilevel strategy for improving virologic suppression in AYA aged 15–24 years living with HIV in East Africa.
methodsThe HIP-CY study uses a type II hybrid (effectiveness-implementation) design to evaluate the feasibility, acceptability, fidelity, and cost-effectiveness of two evidence-based HIV prevention and care interventions (CAB LA and SEARCH-YOUTH) across five geographically distinct urban, semiurban, and rural sites in Uganda. We use the CFIR and RE-AIM frameworks to guide data collection and analysis. DISCUSSION: Our findings will provide insights into differentiated service delivery models for CAB LA and support policies that integrate CAB LA and contextualized multilevel HIV care interventions (SEARCH-YOUTH) for AYA in real-world health service delivery to reduce the incidence of HIV in Ugandan youth. Stakeholder engagement will inform scalable, policy-aligned solutions for sustainable HIV prevention and care and contribute to broader HIV control efforts across SSA.
trial registrationNCT06474364 Registered 13 June 20 244, https://clinicaltrials.ucsf.edu/trial/NCT06474364 . Protocol version 6, dated 16 April 2025. Amendments from versions 1 to 4 incorporated REC recommendations and updated the Investigators Roster. Protocol versions 4 to 6 were updated to align with the Ministry of Health directive on integrating HIV care into chronic medical conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.